OA09430A - "Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant". - Google Patents

"Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant".

Info

Publication number: OA09430A
Authority: OA; OAPI
Prior art keywords: image; pharmaceutical compositions; preparation process; compositions containing; new derivatives
Prior art date: 1988-10-17

Application number

OA59664A

Other languages

English (en)

French (fr)

Inventor

Regnier Gilbert

Dhainaut Alain

Vilaine Jean-Paul

Villeneuve Nicole

Joly Ghislaine

Duhault Jacques

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-17

Filing date

1989-10-17

Publication date

1992-10-15

1989-10-17 Application filed by Adir filed Critical Adir

1992-10-15 Publication of OA09430A publication Critical patent/OA09430A/xx

Links

XPKQHJJKXONCHR-UHFFFAOYSA-N 2-amino-3,4-dihydrochromen-2-ol Chemical class C1=CC=C2OC(N)(O)CCC2=C1 XPKQHJJKXONCHR-UHFFFAOYSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
102000004257 Potassium Channel Human genes 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000004913 activation Effects 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000004472 dialkylaminosulfonyl group Chemical group 0.000 abstract 1
230000001079 digestive effect Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002526 effect on cardiovascular system Effects 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
108020001213 potassium channel Proteins 0.000 abstract 1
HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical class O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
230000016160 smooth muscle contraction Effects 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
230000002485 urinary effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Peptides Or Proteins (AREA)

OA59664A 1988-10-17 1989-10-17 "Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant". OA09430A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8813637A FR2637896B1 (fr)	1988-10-17	1988-10-17	Nouveaux derives de l'amino chromanol, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number	Publication Date
OA09430A true OA09430A (fr)	1992-10-15

Family

ID=9371088

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA59664A OA09430A (fr)	1988-10-17	1989-10-17	"Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant".

Country Status (15)

Country	Link
US (1)	US4999372A (ja)
EP (1)	EP0365416B1 (ja)
JP (1)	JPH068296B2 (ja)
AT (1)	ATE94543T1 (ja)
AU (1)	AU620157B2 (ja)
CA (1)	CA2000743A1 (ja)
DE (1)	DE68909167T2 (ja)
DK (1)	DK492089A (ja)
ES (1)	ES2059802T3 (ja)
FR (1)	FR2637896B1 (ja)
IE (1)	IE64369B1 (ja)
NZ (1)	NZ231029A (ja)
OA (1)	OA09430A (ja)
PT (1)	PT92007B (ja)
ZA (1)	ZA897821B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1216461B (it) *	1988-02-26	1990-03-08	Milano	Derivati del 1_aril solfonil2_pirrolidinone loro procedimentodi preparazione e loro impieto come medicinali.
IT1244881B (it) *	1990-12-13	1994-09-12	Roussel Pharma Spa	Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti ,il loro impiego come farmaci e le composizioni farmaceutiche che li contengono

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1495526A (en) *	1974-05-31	1977-12-21	Beecham Group Ltd	Chroman derivatives
DE3579390D1 (de) *	1984-06-22	1990-10-04	Beecham Group Plc	Wirksame benzopyranverbindungen.
GB8625185D0 (en) *	1986-10-21	1986-11-26	Beecham Group Plc	Active compounds
DE3881714D1 (de) *	1987-02-04	1993-07-22	Hoechst Ag	Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.

1988
- 1988-10-17 FR FR8813637A patent/FR2637896B1/fr not_active Expired - Lifetime
1989
- 1989-10-05 DK DK492089A patent/DK492089A/da not_active Application Discontinuation
- 1989-10-11 US US07/419,824 patent/US4999372A/en not_active Expired - Fee Related
- 1989-10-16 PT PT92007A patent/PT92007B/pt not_active IP Right Cessation
- 1989-10-16 CA CA002000743A patent/CA2000743A1/fr not_active Abandoned
- 1989-10-16 ZA ZA897821A patent/ZA897821B/xx unknown
- 1989-10-16 IE IE331889A patent/IE64369B1/en not_active IP Right Cessation
- 1989-10-16 AU AU42872/89A patent/AU620157B2/en not_active Ceased
- 1989-10-16 NZ NZ231029A patent/NZ231029A/xx unknown
- 1989-10-17 DE DE89402857T patent/DE68909167T2/de not_active Expired - Fee Related
- 1989-10-17 ES ES89402857T patent/ES2059802T3/es not_active Expired - Lifetime
- 1989-10-17 JP JP1270154A patent/JPH068296B2/ja not_active Expired - Lifetime
- 1989-10-17 OA OA59664A patent/OA09430A/xx unknown
- 1989-10-17 EP EP89402857A patent/EP0365416B1/fr not_active Expired - Lifetime
- 1989-10-17 AT AT89402857T patent/ATE94543T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE68909167T2 (de)	1994-04-14
EP0365416A1 (fr)	1990-04-25
CA2000743A1 (fr)	1990-04-17
AU4287289A (en)	1990-04-26
IE64369B1 (en)	1995-07-26
IE893318L (en)	1990-04-17
NZ231029A (en)	1990-10-26
ES2059802T3 (es)	1994-11-16
FR2637896B1 (fr)	1990-11-30
PT92007B (pt)	1995-06-30
ATE94543T1 (de)	1993-10-15
US4999372A (en)	1991-03-12
PT92007A (pt)	1990-04-30
AU620157B2 (en)	1992-02-13
JPH02149578A (ja)	1990-06-08
EP0365416B1 (fr)	1993-09-15
DK492089A (da)	1990-04-18
ZA897821B (en)	1990-07-25
DK492089D0 (da)	1989-10-05
DE68909167D1 (de)	1993-10-21
FR2637896A1 (fr)	1990-04-20
JPH068296B2 (ja)	1994-02-02

Publication	Publication Date	Title
HUT38256A (en)	1986-05-28	Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts
NO870331D0 (no)	1987-01-27	Fremgangsmaate ved fremstilling av vinylfenolderivater.
LU92099I2 (fr)	2013-01-16	Golimumab et ses dérivés pharmaceutiquement acceptables (SIMPONI®)
GEP20032958B (en)	2003-04-25	Adenosine Derivatives
NO157377C (no)	1988-03-05	Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazodiazepiner.
PT73280A (de)	1981-07-01	Neue imidazol-derivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate
DE3856258D1 (de)	1998-11-19	Verfahren zur Herstellung eines Retardpräparates, das Diltiazem in einer einzigen Tagesdosis enthält
KR830002510A (ko)	1983-05-30	생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
OA09430A (fr)	1992-10-15	"Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant".
US5278172A (en)	1994-01-11	Method and composition for treating tendon or joint inflammation using a vasodilator
JPH02326B2 (ja)	1990-01-08
KR890012942A (ko)	1989-09-20	5-치환된 오르니틴 유도체
PT79969B (de)	1987-02-02	Isoxazol-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
KR910004609A (ko)	1991-03-29	아미노케톤 유도체 및 그의 용도
AU527523B2 (en)	1983-03-10	Hexahydro-1,4-oxazepines
OA09451A (fr)	1992-10-15	"Nouveaux dérivés de la pyrrolidone, leur procédé de préparation et les compositions pharmaceutiques les renfermant".
OA08237A (fr)	1987-10-30	Nouveaux dérivés du triazole leur procédé de préparation et les compositions pharmaceutiques les renfermant
KR880002521A (ko)	1988-05-09	약제 제형
KR930004647B1 (ko)	1993-06-02	신장 질환 치료제
Munthe et al.	1983	Is gold necessary in so called chrysotherapy?
KR920703593A (ko)	1992-12-18	이미다조퀴녹살린 화합물, 이의 제조방법 및 용도
KR910018026A (ko)	1991-11-30	α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
KR910018347A (ko)	1991-11-30	술포닐알칸산 아미드 유도체